NCT02744378View on ClinicalTrials.gov

Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

December 31, 2015

Conditions
Oral Lichen Planus
Interventions
DRUG

Tacrolimus 0.1%

This group was randomly allocated to receive topical Tacrolimus 0.1% for 3 consecutive weeks

DRUG

Clobetasol 0.05%

This group was randomly allocated to receive topical Clobetasol 0.05% for 3 consecutive weeks

All Listed Sponsors
lead

University of Peradeniya

OTHER

NCT02744378 - Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus | Biotech Hunter | Biotech Hunter